People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RegenX Science Inc. | — | Biotechnology | Series A | $5.0M | $62.4M | 2022 |
| Panacea Oyster Co-op Corp | — | Other | Seed | $1.5M | $27.9M | 2016 |
Elisabeth Corson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elisabeth Corson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jamie Grooms | 1 | 4 |
| Robin Olin | 1 | 1 |
| Robert Seidler | 1 | 1 |
| Jerry Moore | 1 | 1 |
| Joel Singletary | 1 | 1 |
| Bob Ballard | 1 | 1 |
| Zheng Cao | 1 | 1 |
| Zach Ferrell | 1 | 1 |
| Jill Waibel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.